Tenax Therapeutics, Inc. (TENX)
NASDAQ: TENX · Real-Time Price · USD
5.87
+0.11 (1.91%)
Jul 9, 2025, 4:00 PM - Market closed

Tenax Therapeutics Market Cap

Tenax Therapeutics has a market cap or net worth of $233.00 million as of July 9, 2025. Its market cap has increased by 3,849.09% in one year.

Market Cap
233.00M
Enterprise Value
121.69M
1-Year Change
3,849.09%
Ranking
Category
Stock Price
$5.87

Market Cap Chart

Since October 31, 2001, Tenax Therapeutics's market cap has increased from $13.80M to $233.00M, an increase of 1,588.38%. That is a compound annual growth rate of 12.66%.

History

DateMarket Cap% Change
Jul 8, 202523.90M13.27%
Dec 31, 202421.10M219.70%
Dec 29, 20236.60M32.00%
Dec 30, 20225.00M-80.92%
Dec 31, 202126.20M11.49%
Dec 31, 202023.50M147.37%
Dec 31, 20199.50M427.78%
Dec 31, 20181.80M-86.96%
Dec 29, 201713.80M-74.82%
Dec 30, 201654.80M-40.63%
Dec 31, 201592.30M-14.54%
Dec 31, 2014108.00M125.94%
Dec 31, 201347.80M123.36%
Dec 31, 201221.40M-45.69%
Dec 30, 201139.40M-13.41%
Dec 31, 201045.50M-62.86%
Dec 31, 2009122.50M213.30%
Dec 31, 200839.10M-10.93%
Dec 31, 200743.90M92.54%
Dec 29, 200622.80M25.97%
Dec 30, 200518.10M-40.66%
Dec 31, 200430.50M-57.04%
Dec 31, 200371.00M332.93%
Dec 31, 200216.40M18.84%
Dec 31, 200113.80M-
View and export this data all the way back to 2001. Sign Up Today.

Market Capitalization

Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.

Formula: Market Cap = Stock Price * Shares Outstanding
Full Definition

Related Stocks

Company Market Cap
Eli Lilly and Company 700.84B
Johnson & Johnson 375.37B
AbbVie 334.34B
Novo Nordisk 316.33B
UnitedHealth Group 279.90B
Novartis AG 242.35B
Abbott Laboratories 233.90B
AstraZeneca 218.65B
Market Cap Rankings